GoodRx Holdings, Inc. Overview
Pro stress-test →GoodRx operates a digital healthcare platform designed to help consumers compare prescription drug prices at retail pharmacies across the United States. Through its website and mobile applications, GoodRx aggregates pricing and discount information from a wide network of pharmacies, enabling users to access coupons and savings programs on both generic and brand-name medications.
Strategic Profile
Pro stress-test →The company reported marginal revenue and EBITDA growth for 2025, with the business mix shifting rapidly toward high-margin Pharma Direct offerings and away from its legacy prescription transactions. Management described a business model transformation, prioritizing direct-to-consumer and employer-integrated pricing platforms, and locking in long-term partnerships with retail pharmacies. The company is increasingly orienting around its Pharma Manufacturer Solutions business—now rebranded as GoodRx Pharma Direct—as a key growth driver.
Competitive Landscape
Pro stress-test →GoodRx competes in prescription price transparency and pharmacy savings alongside large tech platforms (Amazon Pharmacy, Google), PBM-owned solutions, and telehealth providers. Regulatory changes and industry consolidation threaten GoodRx's core business model, while rising competition from large tech and retail platforms, along with stricter data privacy rules, risks reducing user engagement and limiting monetization options.
Industry Context
GoodRx Holdings, Inc. operates in Digital Healthcare / Prescription Price Transparency / Healthcare Technology.
Key facts
Founded: 2011 · Headquarters: Santa Monica, United States · Revenue: $797M · Market cap: $674M